Article
Activation of distinct inflammatory pathways in subgroups of LR-MDS
7 Jul 2023
Abstract excerpt
Aberrant innate immune signaling has been identified as a potential key driver of the complex pathophysiology of myelodysplastic neoplasms (MDS). This study of a large, clinically and genetically well-characterized cohort of treatment-naïve MDS patients confirms intrinsic activation of inflammatory pathways in general mediated by caspase-1, interleukin (IL)-1β and IL-18 in low-risk (LR)-MDS bone marrow and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
